Abstract
5.21 ROR1-Immunotoxin as a Potential Therapeutic Agent for Certain Human B-cell Malignancies Sivasubramanian Baskar, Adrian Wiestner, Wyndham H. Wilson, Ira Pastan, Christoph Rader Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute; Hematology Branch, National Heart, Lung and Blood Institute and Metabolism Branch, Center for Cancer Research, National Cancer Institute; Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
